Last reviewed · How we verify

Steroid Drug (prednisolone) — Competitive Intelligence Brief

Steroid Drug (prednisolone) (Steroid Drug (prednisolone)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid (glucocorticoid). Area: Immunology, Rheumatology, Endocrinology.

marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR) Immunology, Rheumatology, Endocrinology Small molecule Live · refreshed every 30 min

Target snapshot

Steroid Drug (prednisolone) (Steroid Drug (prednisolone)) — Lumbini Medical College. Prednisolone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Steroid Drug (prednisolone) TARGET Steroid Drug (prednisolone) Lumbini Medical College marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Solu-medrol or placebo administration Solu-medrol or placebo administration Erasme University Hospital marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Methylprednisolone/prednisolone Methylprednisolone/prednisolone Chong Kun Dang Pharmaceutical marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Prednisone/Prednisolone Prednisone/Prednisolone Organon and Co marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Dex infusion Dex infusion Seoul National University Hospital marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
phosphate and betamethasone acetate, 2 mL. phosphate and betamethasone acetate, 2 mL. Hospital Italiano de Buenos Aires marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Solu-Cortef Solu-Cortef Haukeland University Hospital marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticosteroid (glucocorticoid) class)

  1. Assistance Publique - Hôpitaux de Paris · 3 drugs in this class
  2. Astellas Pharma Inc · 2 drugs in this class
  3. Sanofi · 2 drugs in this class
  4. Xinqiao Hospital of Chongqing · 2 drugs in this class
  5. Berinstein, Jeffrey · 2 drugs in this class
  6. Ain Shams University · 2 drugs in this class
  7. Children's Hospital of Philadelphia · 1 drug in this class
  8. Celgene · 1 drug in this class
  9. Hamilton Health Sciences Corporation · 1 drug in this class
  10. Erasme University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Steroid Drug (prednisolone) — Competitive Intelligence Brief. https://druglandscape.com/ci/steroid-drug-prednisolone. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: